CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...
CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...
CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
LUIGI X. CUBEDDU<br />
116. Fuenmayor, N.T., Moreira, E and <strong>Cubeddu</strong>, L.X. Salt sensitivity and insulin resistance in essential<br />
hypertension. Am. J Hypert. 4:397-402, 1998.<br />
117. Castejon, A.M and <strong>Cubeddu</strong>, L.X. Level <strong>of</strong> punishment determines anticonflict activity <strong>of</strong> ondansetron in<br />
pigeons: comparison with buspirone and diazepam. Pharmacol Biochem Behavior. 61:451-457, 1998.<br />
118. Castejon AM, Paez X, Hernandez L and <strong>Cubeddu</strong> LX. Use <strong>of</strong> intravenous microdialysis to monitor<br />
changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects<br />
<strong>of</strong> granisetron and ondansetron. J Pharmacol Exp Ther. 291(3):960-966, 1999.<br />
119. <strong>Cubeddu</strong> LX, Bonisch H, Gothert M, Molderings G, Racke K, Ramadori G, Miller KJ, Schworer H.<br />
Effects <strong>of</strong> metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors. Naunyn<br />
Schmiedebergs Arch Pharmacol. 361(1):85-91, 2000.<br />
120. Ischia R, Gasser RW, Fischer-Colbrie R, Eder U, Pagani A, <strong>Cubeddu</strong> LX, Lovisetti-Scamihorn P,<br />
Finkenstedt G, Laslop A, Winkler H. Levels and molecular properties <strong>of</strong> secretoneurin-immunoreactivity<br />
in the serum and urine <strong>of</strong> control and neuroendocrine tumor patients. J Clin Endocrinol Metab. 85(1):355-<br />
360, 2000.<br />
121. Alfieri A.B. and <strong>Cubeddu</strong> L.X. Role <strong>of</strong> NK1 receptors on cisplatin-induced nephrotoxicity in the rat.<br />
Naunyn Schmiedeberg’s Arch Pharmacol .361(3):334-338, 2000.<br />
122. <strong>Cubeddu</strong> LX, Alfieri AB, H<strong>of</strong>fmann IS, Jimenez E, Roa MC, <strong>Cubeddu</strong> RC. Nitric oxide and salt<br />
sensitivity. Am J Hypertens. 13:973-979, 2000.<br />
123. <strong>Cubeddu</strong> LX, H<strong>of</strong>fmann IS, Jimenez E, Roa CM, <strong>Cubeddu</strong> RJ, Palermo C and Baldonedo RM. Insulin<br />
and blood pressure responses to changes in salt intake. J Human Hypertens. 14:S32-S35, 2000.<br />
124. Alfieri A.B., Rodriguez-Plaza L and <strong>Cubeddu</strong> L.X. Effects <strong>of</strong> short- and long-term exercise on urinary<br />
cGMP excretion in healthy subjects and in patients with coronary artery disease. J Cardiovasc Pharmacol<br />
35:891-896, 2000.<br />
125. Alfieri A.B. and <strong>Cubeddu</strong> L.X. Role <strong>of</strong> NK1 receptors and nitric oxide on cyclophosphamide-induced<br />
bladder toxicity . J Pharmacol Exp Ther. 295:824-829, 2000.<br />
126. Alfieri AB, Malave A and <strong>Cubeddu</strong> LX: Nitric oxide synthases and cyclophosphamide-induced cystitis in<br />
rats.<br />
Naunyn Schmiedebergs Arch Pharmacol. 363(3):353-357, 2001.<br />
127. Xu X, <strong>Cubeddu</strong> LX and Malave A. Expression <strong>of</strong> inducible nitric oxide synthase in primary culture <strong>of</strong> the rat<br />
bladder smooth muscle by plasma from cyclophosphamide-treated rats. Eur J Pharmacol. 416:1-9, 2001.<br />
128. H<strong>of</strong>fmann, IS, Jimenez E and <strong>Cubeddu</strong> LX. Urinary albumin excretion in lean, overweight and obese<br />
glucose tolerant individuals: its relationship with dyslipidemia, hyperinsulinemia and blood pressure. J<br />
Human Hyperten. 15:407-412, 2001.<br />
129. H<strong>of</strong>fmann IS, Guevara BH and <strong>Cubeddu</strong> LX. Potassium, Muscarinic M3 receptors and dopamine release.<br />
Neurosci Res Comm. Brain Res. 29:1530,2001.<br />
130. H<strong>of</strong>fmann IS and <strong>Cubeddu</strong> LX. Clustering <strong>of</strong> silent cardiovascular risk factors in apparently healthy<br />
Hispanics.<br />
J Hum Hypertens. 16 Suppl 1:S137-141, 2002.<br />
15
Change language